Ousted CytoDyn CEO Pourhassan indicted for alleged securities fraud

Pourhassan allegedly made false and misleading representations about the company's investigational drug, leronlimab.

Source: bizjournals.com Health Care News Headlines - December 20, 2022 Category: Health Management Authors: Elizabeth Hayes Source Type: news